首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

1424409

製藥 4.0 全球市場，按成分、按技術、按應用、按最終用戶、按地區

Global Pharma 4.0 Market, By Component, By Technology, By Application, By End User, By Geography

出版日期: 2024年01月10日 | 出版商:

Coherent Market Insights | 英文 178 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球製藥4.0市場規模預計將從2024年的167.5億美元增至2031年的544.3億美元，預測期內複合年成長率為18.3%。

報告範圍		報告詳情
基準年	2023年	2023/2024年市場規模	167.5億美元
實際資料	2019年至2023年	預測期	2024-2031
預測期2023/2024~2030/2031年複合成長率：	18.30%	2030/2031價值預測	544.3億美元

圖 1. 2024 年按地區分類的製藥 4.0全球市場佔有率(%)

「製藥4.0」指依照工業4.0原則對製藥業進行轉型。工業4.0的特點是將物聯網（IoT）、人工智慧（AI）、巨量資料分析、雲端運算和網實整合系統等先進技術整合到製造過程中。在製藥業中，這轉化為藥物開發、製造、供應鏈管理和整體業務效率的改善。製藥4.0是指製藥業的第四次工業革命，其特點是物聯網（IoT）、巨量資料分析、人工智慧（AI）和機器學習等先進技術的融合。這些技術正在徹底改變醫藥價值鏈的許多方面，從研發到臨床試驗和生產。我們也透過幫助製藥公司開發創新的標靶治療和精準醫療來實現個人化醫療保健。隨著領先公司擴大採用這些新興技術來最大限度地降低成本、提高生產力並獲得競爭優勢，全球製藥 4.0 市場預計將在未來幾年顯著成長。

市場動態：

全球製藥 4.0 市場的推動因素包括改進藥物研發和市場開拓流程的需求不斷成長、對個性化藥物的需求不斷增加、對製造業務數位化的日益關注以及製藥公司旨在提高供應鏈可視性和效率。幾個因素，包括企業目標。然而，引入新技術所需的高投資成本以及安全漏洞和網路攻擊的風險為市場成長帶來了挑戰。 Pharma 4.0 透過實現資料驅動的研發、臨床試驗和供應鏈中斷的預測分析、新數位療法的開發以及採用 3D 列印進行定製藥物製造，提供了巨大的機會。主要企業正在專注於新產品的發布和合作夥伴關係，以利用這些機會。

本研究的主要特點

本報告對全球製藥4.0市場進行了詳細分析，並提供了以2023年為基準年的預測期（2024-2031）的市場規模和年複合成長率（CAGR%）。
它還揭示了各個細分市場的潛在商機，並為該市場說明了一系列有吸引力的投資提案。
它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的重要考察。
它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球製藥 4.0 市場的主要企業。
該報告的見解使行銷人員和公司負責人能夠就未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。
全球製藥 4.0 市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
透過用於分析全球製藥 4.0 市場的各種策略矩陣，促進相關人員的決策。

北美洲
美國
加拿大
歐洲
德國
英國
西班牙
法國
義大利
俄羅斯
其他歐洲國家
亞太地區
中國
印度
日本
澳洲
韓國
ASEAN
其他亞太地區
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
中東
海灣合作理事會國家
以色列
其他中東地區
非洲
北非
中部非洲
南非

第10章競爭形勢

公司簡介
- Oracle
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare

第11章章節

參考
調查方法
關於出版商

簡介目錄

Product Code: CMI6542

The global pharma 4.0 market size is expected to reach US$ 54.43 Bn by 2031 from US$ 16.75 Bn in 2024, exhibiting a compound annual growth rate (CAGR) of 18.3% during the forecast period.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 16.75 Bn
Historical Data for:	2019 to 2023	Forecast Period:	2024-2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	18.30%	2030/2031 Value Projection:	US$ 54.43 Bn

Figure 1. Global Pharma 4.0 Market Share (%), By Region, 2024

The term "Pharma 4.0" refers to the transformation in the pharmaceutical industry that is aligned with the principles of Industry 4.0. Industry 4.0 is characterized by the integration of advanced technologies such as the Internet of Things (IoT), artificial intelligence (AI), big data analytics, cloud computing, and cyber-physical systems into manufacturing processes. In the context of the pharmaceutical industry, this translates to improvements in drug development, manufacturing, supply chain management, and overall operational efficiency. Pharma 4.0 refers to the fourth industrial revolution in the pharmaceutical industry, characterized by the integration of advanced technologies like the Internet of Things (IoT), big data analytics, artificial intelligence (AI), and machine learning. These technologies are revolutionizing various aspects of the pharmaceutical value chain from research and development, clinical trials, production. They are also enabling personalized healthcare by helping pharma companies develop innovative targeted therapies and precision medicine. The global pharma 4.0 market is projected to grow significantly in the coming years as major players are increasingly adopting these emerging technologies to minimize costs, enhance productivity, and gain a competitive edge.

Market Dynamics:

The global pharma 4.0 market is driven by several factors, such as the growing need to improve drug discovery and development processes, rising demand for personalized medicines, an increasing focus on digitalizing manufacturing operations, and the aims of pharmaceutical companies to enhance supply chain visibility and efficiency. However, the high investment costs required for the implementation of emerging technologies, the risks of security breaches, and cyberattacks pose challenges to market growth. Pharma 4.0 offers huge opportunities by enabling data-driven research and development, predictive analytics for clinical trials and supply chain disruptions, the development of new digital therapies, and the adoption of 3D printing for customized drug manufacturing. Key players are focusing on new product launches and partnerships to capitalize on these opportunities.

Key features of the study:

This report provides in-depth analysis of the global pharma 4.0 market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pharma 4.0 market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study Oracle,GE Healthcare, Optum, Inc., Honeywell International Inc., IBM Corporation, Cisco Systems, Inc., Siemens Healthcare GmbH, POLARISqb, Google Cloud, Optibrium, Syntekabio, Fujitsu Limited, SAS Health, Microsoft and Lotte Healthcare
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global pharma 4.0 market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pharma 4.0 market

Detailed Segmentation:

Global Pharma 4.0 Market, By Component
- Hardware
- Software
- Services
Global Pharma 4.0 Market, By Technology
- Cloud Computing
- Artificial Intelligence
- Big Data Analytics
- Internet of Things
Global Pharma 4.0 Market, By Application
- Research and Development
- Manufacturing
- Supply Chain Management
- Others
Global Pharma 4.0 Market, By End User
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Contract Research Organizations
Global Pharma 4.0 Market, By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Global Pharma 4.0 Market:
- Oracle
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc.
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Component
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing Product Launch
- Data Security and Privacy Concerns
- Advancements in Artificial Intelligence and Analytics
Key Highlights
Regulatory Scenario
Market Trends
PEST Analysis
PORTER's Analysis
Product Launches
Technological Advancements
Mergers, Acquisitions, and Collaborations

4. Global Pharma 4.0 Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Pharma 4.0 Market, By Component, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hardware
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Pharma 4.0 Market, By Technology, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Cloud Computing,
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Artificial Intelligence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Big Data Analytics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Internet of Things
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Pharma 4.0 Market, By Application, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Research and Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Manufacturing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Supply Chain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Pharma 4.0 Market, By End User, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Contract Manufacturing Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
Contract Research Organizations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Pharma 4.0 Market, By Region, 2019-2031, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020 -2031
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Component, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profile
- Oracle
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- GE Healthcare
- Optum, Inc.
- Honeywell International Inc.
- IBM Corporation
- Cisco Systems, Inc
- Siemens Healthcare GmbH
- POLARISqb
- Google Cloud
- Optibrium
- Syntekabio
- Fujitsu Limited
- SAS Health
- Microsoft
- Lotte Healthcare
Analyst Views